Critical Management of Cardiac Amyloidosis: Demystifying a Silent Villian

Friday, May 31st, 2024
8:00 a.m. – 9:00 a.m.
Participate via Microsoft Teams or on Campus Mayo 2-002N. Recording will be available through the Video Exchange.

Presented by: Michael Smith, M.D., M.S.
Anesthesiology and Perioperative Medicine and Critical Care Medicine
Mayo Clinic
Disclosure Statement: Dr. Michael Smith has no relevant financial relationships and does not intend to discuss off label / investigational usage of a product. 

Learning Objectives
Upon conclusion of this program, participants should be able to:

• Identify the two major amyloid types that cause cardiac amyloidosis.​
• Describe findings on echocardiography and other testing associated with cardiac amyloidosis​
• Identify the associated risk factors in critical management of patients with cardiac amyloidosis​
• Evaluate available data in reference to anesthetic management, surgical candidacy, and use of mechanical support.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.